Omicron News and Research

RSS

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Researchers assess the impact of COVID-19 vaccination on immune responses during a breakthrough infection.

9 Feb 2023

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous vaccination improves the neutralization of SARS-CoV-2 Omicron sub-variants.

9 Feb 2023

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins

The infamous spike proteins on the surface of SARS-CoV-2 help it bind to and enter human cells. Because of their important role in spreading infection, these spike proteins are one of the main targets for COVID-19 vaccines and treatments.

9 Feb 2023

Comparison of pre- and post-Omicron disease severity among unvaccinated people without risk factors

In a recent study posted to the medRxiv* preprint server, researchers in Sweden investigated coronavirus disease 2019 (COVID-19) severity among unvaccinated adults during the periods of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) dominance compared to the severity of pre-Omicron VOC infections.

8 Feb 2023

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Researchers correlate SARS-CoV-2 load and neutralizing capacity of all saliva immunoglobulins isotypes in asymptomatic individuals.

8 Feb 2023

Do individuals with long COVID ever recover fully?

Researchers investigate the sociodemographic factors that contribute to the remission of long COVID.

7 Feb 2023

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers analyzed data from the Increasing Community Access to Testing (ICATT), a nationwide pharmacy program run in the US for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.

7 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

How did human mobility affect COVID-19 case growth?

A new study posted to the medRxiv* preprint server investigated how human mobility influenced SARS-CoV-2 transmission, based on a network-based approach and panel regression methods.

6 Feb 2023

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

A new study on the medRxiv* preprint server assessed whether a novel assay could detect VOCs without substantial reductions in sensitivity.

6 Feb 2023

Virus Watch: A cohort study of COVID-19 in households of England and Wales

A new study posted on the pre-print medRxiv* aimed to discuss how Virus Watch provided public health approaches that were effective for the investigation of community incidence, symptom profiles, and the transmission of COVID-19, as well as the effectiveness of the COVID-19 vaccines.

5 Feb 2023

Proteomics reveals a distinct IFN-driven plasma cytokine response to COVID-19 in infants and young children

Researchers assesses immune responses to SARS-CoV-2 shortly after birth using a multi-omics approach.

5 Feb 2023

The effectiveness of intranasal COVID-19 vaccination in healthy adults

A recent study discusses the safety profiles and immunogenicity of the nasal BBV154 COVID-19 vaccine in healthy adults.

3 Feb 2023

Where does COVID-19 rank as an underlying cause of death for children and young people in the US?

A study published in JAMA Network Open ranks COVID-19 in 8th position among all causes of death in children and young adults aged 0 to 19 years in the United States.

2 Feb 2023

Establishment of a rapid and accurate SARS-CoV-2 antigen detection kit able to identify Omicron mutants

Researchers developed an antigen detection kit to identify the SARS-CoV-2 Omicron variant of concern.

2 Feb 2023

What is the incidence of COVID-19-associated febrile seizures in children?

Researchers investigated the incidence of febrile seizures among SARS-CoV-2-positive children.

2 Feb 2023

New study suggests Omicron BA.1 breakthrough infection drives long-term remodeling of memory B cell repertoire in vaccinated populations

A recent study posted on the bioRxiv* preprint server has longitudinally characterized the MBC repertoire and humoral response after Omicron BA.1 breakthrough infection in individuals vaccinated with the COVID-19 mRNA vaccine.

1 Feb 2023

Could novel lineages eventually dominate the viral population?

A new study puts forward a bottom-up approach to quickly predict whether a lineage will dominate the viral population, at a particular geographical location.

1 Feb 2023

Breakthrough Omicron BA.1/BA.2 infections in the triple-vaccinated linked to broad-based immunity

A new study looked at the whole spectrum of immunological reactions raised by spike and non-spike antigens following Omicron BA.1/BA.2 infections in such individuals, both with and without prior SARS-CoV-2 infection.

1 Feb 2023

Omicron News and Research

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Researchers discover small molecules that can lock SARS-CoV-2 spike proteins

Comparison of pre- and post-Omicron disease severity among unvaccinated people without risk factors

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Do individuals with long COVID ever recover fully?

Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

How did human mobility affect COVID-19 case growth?

Detecting novel SARS-CoV-2 variants via rapid RT-PCR assays

Virus Watch: A cohort study of COVID-19 in households of England and Wales

Proteomics reveals a distinct IFN-driven plasma cytokine response to COVID-19 in infants and young children

The effectiveness of intranasal COVID-19 vaccination in healthy adults

Where does COVID-19 rank as an underlying cause of death for children and young people in the US?

Establishment of a rapid and accurate SARS-CoV-2 antigen detection kit able to identify Omicron mutants

What is the incidence of COVID-19-associated febrile seizures in children?

New study suggests Omicron BA.1 breakthrough infection drives long-term remodeling of memory B cell repertoire in vaccinated populations

Could novel lineages eventually dominate the viral population?

Breakthrough Omicron BA.1/BA.2 infections in the triple-vaccinated linked to broad-based immunity

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News